Items Tagged with 'Tenet Healthcare Corporation'

ARTICLES

THC Extends Tender Offer

Tenet Announces Extension of Cash Tender Offer for 7.375% Senior Notes due 2013

On October 29, 2012, Tenet Healthcare Corporation (NYSE: THC) announced that it has exercised its option to extend its previously announced cash tender offer to purchase any and all of the $216.361 million aggregate principal amount outstanding of its 7.375% Senior Notes due 2013 until 12:00 midnight, New York City time, on October 31, 2012.


Read More
THC Reports Adjusted EBITDA of $288 Million

Tenet Healthcare Financials Announced

On August 7, 2012, Tenet Healthcare Corporation (NYSE: THC) announced second quarter 2012 financial and operational results.


Read More
THC Repurchases $300mm in Stock, Announces Prelimary Financials

Tenet Repurchase, Preliminary Results Announced

On April 26, 2012, Tenet Healthcare Corporation (NYSE:THC) announced it has repurchased $299 million of mandatory convertible preferred stock.


Read More
Tenet Healthcare Predicts 2012 Increase in Strategic Initiatives

Tenet Financials Released

On February 28, 2012, Tenet Healthcare Corporation (NYSE:THC) reported adjusted EBITDA of $294 million for the fourth quarter ended December 31, 2011, an increase of $13 million, or 4.6%, compared to $281 million for the fourth quarter of 2010.


Read More

Tenet Healthcare Outlook Issued

On January 9, 2012, Tenet Healthcare Corporation (NYSE:THC) issued its outlook for 2012 with adjusted EBITDA in a range of $1.200 billion to $1.300 billion.


Read More

Tenet Healthcare Tender Offer Completed

On December 6, 2011, Tenet Healthcare Corporation (NYSE: THC) announced completion of its previously-announced cash tender offer to purchase any and all of the $714.012 million aggregate principal amount outstanding of its 9.0% Senior Secured Notes due 2015.


Read More

Learn & Avoid These 10 Common Mistakes

Free Report: Turnaround Investing Mistakes

Turnaround Investing Blog

Turnaround Investing Blog

A Closer Look At Two Activist Campaigns

Watch to see if ADP’s CEO Carlos Rodriguez inadvertently helps Pershing, and his aggressive and sometimes personal stance against Ackman could backfire. Overall, because of the stock’s strong returns and Ackman’s weak credibility, we would give this activist campaign a low chance of making ADP a successful turnaround investment. For turnaround investors, the Trian campaign appears to have a win-win opportunity for investors--either Peltz joins the board and learns enough to re-invigorate P&G, or loses and management must either execute (boosting earnings and the shares) or they will face a more drastic proxy campaign with higher odds of success down the road. We think the P&G campaign could turn out well for shareholders.  Read More.

Warrants: A Solid Investment Opportunity

Warrants provide a valuable tool for the savvy investor. When selected and implemented well, they can be a smart addition to a diversified investor’s portfolio. Like options, warrants are not equity. They only convey the right to buy equity. As such, neither holder is entitled to dividend rights, pre-emptive rights, proxy voting or any share of any liquidation.

 

Value Investing

 

Warrants' return potential can be very high, but they also carry significant risks. Learn what they are, how they work, strategies to minimize risk and find profit with warrants.

Here's Why You Should Invest in Asset Managers

 

stock market advicex

 

This Forbes article cites a recent MoneyShow write-up that recommends investors take advantage of the strong stock market and potential interest rate hike by "putting some of your investment assets into the shares of asset management stocks."

 

The article praises The Turnaround Letter's OAK purchase recommendation and quotes George Putnam: "As the corporate debt binge that we’ve experienced since 2009 comes to an end, Oaktree will benefit from a growing number of restructurings and bankruptcies."  

 

Learn more about Putnam's investing success with turnaround stocks.